Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 nov. 2022 17h19 HE | Source: AIM Stockholder Full Value Committee

Statement of the ASFV Committee on Ruling in Delaware Action

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Jonathan Jorgl, an AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) stockholder, together with his nominees, Robert L. Chioini and Michael Rice...
24 oct. 2022 08h30 HE | Source: AIM Stockholder Full Value Committee

ASFV Committee Reveals Troubling Statements Made by Entrenched AIM Board Uncovered Through Discovery in Delaware Action

NEW YORK, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Jonathan Jorgl, an AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) stockholder, together with his nominees, Robert L. Chioini and Michael Rice...
13 oct. 2022 10h32 HE | Source: AIM Stockholder Full Value Committee

U.S. District Court Dismisses AIM’s "Baseless" Section 13(d) Claim

Court Rules that Allowing Claim to Proceed Would be Inconsistent with StatutoryPurpose of Investor Protection AIM’s Stock Price Continues Dramatic Decline, Closing at New 52-Week Low of $0.479 on...
16 août 2022 16h05 HE | Source: AIM Stockholder Full Value Committee

AIM Stockholder Full Value Committee Reiterates Intent to Proceed with Nominations and Proxy Solicitation

Court Orders AIM Not to Hold Annual Meeting Prior to October 31, 2022 Delaware Court Preliminary Injunction Hearing Scheduled for October 5, 2022 NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) --...
21 juil. 2022 12h26 HE | Source: AIM Stockholder Full Value Committee

UPDATE -- AIM Stockholder Full Value Committee Announces Director Nominations for AIM Annual Meeting and Confirms Intent to Proceed with Proxy Solicitation

NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Jonathan Jorgl, an AIM ImmunoTech Inc. (NYSE American: AIM), (“AIM”) stockholder, together with his nominees, Robert L. Chioini and Michael Rice...
21 juil. 2022 08h30 HE | Source: AIM Stockholder Full Value Committee

AIM Stockholder Full Value Committee Announces Director Nominations for AIM Annual Meeting and Confirms Intent to Proceed with Proxy Solicitation

NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Jonathan Jorgl, an AIM ImmunoTech Inc. (“AIM”) stockholder, together with his nominees, Robert L. Chioini and Michael Rice (collectively, the “AIM...